Nguyen, K. et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children’s Oncology Group study. Leukemia 22, 2142–2150 (2008).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Carroll, W. L. & Raetz, E. A. Clinical and laboratory biology of childhood acute lymphoblastic leukemia. J. Pediatr. 160, 10–18 (2012).ArticleÂ
PubMedÂ
Google ScholarÂ
Hunger, S. P. et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J. Clin. Oncol. 30, 1663–1669 (2012).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Park, J. H. et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N. Engl. J. Med 378, 449–459 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Meyer, J. A. et al. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nat. Genet 45, 290–294 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Evensen, N. A. et al. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica 103, 830–839 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Jones, C. L. et al. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. Blood 126, 2202–2212 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yang, J. J. et al. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood 112, 4178–4183 (2008).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Saint Fleur-Lominy, S. et al. Evolution of the epigenetic landscape in childhood B acute lymphoblastic leukemia and its role in drug resistance. Cancer Res. 80, 5189–5202 (2020).ArticleÂ
CASÂ
PubMed CentralÂ
Google ScholarÂ
Aronson, B. E. et al. A bipartite element with allele-specific functions safeguards DNA methylation imprints at the Dlk1-Dio3 locus. Dev. Cell 56, 3052–3065.e5 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Fortin, J. P. & Hansen, K. D. Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. Genome Biol. 16, 180 (2015).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376–380 (2012).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Nora, E. P. et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 485, 381–385 (2012).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Spielmann, M., Lupianez, D. G. & Mundlos, S. Structural variation in the 3D genome. Nat. Rev. Genet 19, 453–467 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110–114 (2016).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Lupianez, D. G. et al. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell 161, 1012–1025 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kloetgen, A. et al. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. Nat. Genet 52, 388–400 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yusufova, N. et al. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature 589, 299–305 (2021).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Narang, S. et al. NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization. Genome Biol. 24, 64 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xu, J. et al. Subtype-specific 3D genome alteration in acute myeloid leukaemia. Nature 611, 387–398 (2022).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pui, C. H. et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 360, 2730–2741 (2009).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Inaba, H. & Pui, C. H. Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia. J. Clin. Med. 10, 1926 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Inaba, H. & Mullighan, C. G. Pediatric acute lymphoblastic leukemia. Haematologica 105, 2524–2539 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lazaris, C., Kelly, S., Ntziachristos, P., Aifantis, I. & Tsirigos, A. HiC-bench: comprehensive and reproducible Hi-C data analysis designed for parameter exploration and benchmarking. BMC Genomics 18, 22 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, X. et al. Genome-wide detection of enhancer-hijacking events from chromatin interaction data in rearranged genomes. Nat. Methods 18, 661–668 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Akers, N. K., Schadt, E. E. & Losic, B. STAR Chimeric Post for rapid detection of circular RNA and fusion transcripts. Bioinformatics 34, 2364–2370 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Dixon, J. R. et al. Integrative detection and analysis of structural variation in cancer genomes. Nat. Genet 50, 1388–1398 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, S. et al. HiNT: a computational method for detecting copy number variations and translocations from Hi-C data. Genome Biol. 21, 73 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Robinson, J. T. et al. Juicebox.js provides a cloud-based visualization system for Hi-C data. Cell Syst. 6, 256–258.e1 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhang, Y. et al. PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia. Blood 131, 2256–2261 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pui, C. H., Roberts, K. G., Yang, J. J. & Mullighan, C. G. Philadelphia chromosome-like acute lymphoblastic leukemia. Clin. Lymphoma Myeloma Leuk. 17, 464–470 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Devoucoux, M. et al. Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes. Cell Rep. 39, 110947 (2022).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Feng, Y., Li, L., Du, Y., Peng, X. & Chen, F. E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2. J. Cell Mol. Med 24, 2157–2168 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ouyang, X., Handoko, S. D. & Kwoh, C. K. CScore: a simple yet effective scoring function for protein-ligand binding affinity prediction using modified CMAC learning architecture. J. Bioinform Comput Biol. 9, 1–14 (2011).ArticleÂ
PubMedÂ
Google ScholarÂ
Smith, C. A. & Fan, G. The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms. Hum. Pathol. 39, 795–810 (2008).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Mullighan, C. G. et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA 106, 9414–9418 (2009).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tirado, C. A. et al. Novel JAK2 rearrangement resulting from a t(9;22)(p24;q11.2) in B-acute lymphoblastic leukemia. Leuk. Res 34, 1674–1676 (2010).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Waanders, E. et al. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia. Blood Cancer Discov. 1, 96–111 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lee, J. W. et al. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1. Biochem Biophys. Res Commun. 420, 91–95 (2012).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chen, Y., Xiang, H., Zhang, Y., Wang, J. & Yu, G. Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. Clin. Exp. Metastasis 32, 417–428 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Lv, J. et al. PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma. Mol. Med Rep. 16, 4475–4482 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, C. et al. Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas. Oncotarget 8, 10287–10297 (2017).ArticleÂ
PubMedÂ
Google ScholarÂ
Wang, C. et al. Downregulation of PCDH9 predicts prognosis for patients with glioma. J. Clin. Neurosci. 19, 541–545 (2012).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Xiao, X. et al. The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder. Neuropsychopharmacology 43, 1128–1137 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 14, 128 (2013).ArticleÂ
Google ScholarÂ
Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44, W90–W97 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xie, Z. et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 1, e90 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Hogan, L. E. et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 118, 5218–5226 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kaul, A., Bhattacharyya, S. & Ay, F. Identifying statistically significant chromatin contacts from Hi-C data with FitHiC2. Nat. Protoc. 15, 991–1012 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ay, F., Bailey, T. L. & Noble, W. S. Statistical confidence estimation for Hi-C data reveals regulatory chromatin contacts. Genome Res 24, 999–1011 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sheffield, N. C. & Bock, C. LOLA: enrichment analysis for genomic region sets and regulatory elements in R and Bioconductor. Bioinformatics 32, 587–589 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Fragoso, R. et al. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood 107, 1608–1616 (2006).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chow, Y. P., Alias, H. & Jamal, R. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia. BMC Cancer 17, 120 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Oshima, K. et al. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. Nat. Cancer 1, 1113–1127 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
MN1 Linked to syndrome characterized by craniofacial abnormalities and severe developmental delay. Am J Med Genet A 182, 615–616 (2020).Carella, C. et al. MN1 overexpression is an important step in the development of inv(16) AML. Leukemia 21, 1679–1690 (2007).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kang, S. & Hong, S. Molecular pathogenesis of spinocerebellar ataxia type 1 disease. Mol. Cells 27, 621–627 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Alluri, R. V. et al. Molecular analysis of CAG repeats at five different spinocerebellar ataxia loci: correlation and alternative explanations for disease pathogenesis. Mol. Cells 24, 338–342 (2007).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Li, J. et al. ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism. Nat. Commun. 12, 1045 (2021).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yuan, F. et al. A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma. Front Neurol. 12, 704130 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Jiang, Y. et al. [Study on expression and mechanism of serum differential proteins after rush immunotherapy of allergic rhinitis]. Lin. Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 34, 683–689 (2020).
Google ScholarÂ
Reardon, D. A., Hanson, C. A., Roth, M. S. & Castle, V. P. Lineage switch in Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 73, 1526–1532 (1994).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Grosveld, G. C. MN1, a novel player in human AML. Blood Cells Mol. Dis. 39, 336–339 (2007).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Relling, M. V. et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J. Clin. Oncol. 22, 3930–3936 (2004).ArticleÂ
PubMedÂ
Google ScholarÂ
Sherief, L. M. et al. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia. Mol. Genet Genom. Med. 9, e1700 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Toth, K. et al. Retinoids enhance glucocorticoid-induced apoptosis of T cells by facilitating glucocorticoid receptor-mediated transcription. Cell Death Differ. 18, 783–792 (2011).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Lee, Y. et al. ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. Dev. Cell 21, 746–757 (2011).ArticleÂ
CASÂ
PubMed CentralÂ
Google ScholarÂ
Safaei, S. et al. Double sword role of EZH2 in leukemia. Biomed. Pharmacother. 98, 626–635 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Pierro, J. et al. The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia. Mol. Cancer Res 18, 1153–1165 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, J. et al. PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia. Cancer Discov. 12, 186–203 (2022).Martens, J. H. et al. PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. Cancer Cell 17, 173–185 (2010).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Churchman, M. L. et al. Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia. Cancer Cell 28, 343–356 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kaufmann, K. B. et al. A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2. J. Exp. Med. 209, 35–50 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471, 235–239 (2011).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Fu, Y. et al. The histone demethylase PHF8 promotes adult acute lymphoblastic leukemia through interaction with the MEK/ERK signaling pathway. Biochem Biophys. Res. Commun. 496, 981–987 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide. Curr. Protoc. Mol. Biol. 109, 21 29 1–21 29 9 (2015).PubMedÂ
Google ScholarÂ
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res 42, W187–W191 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032–2034 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ross-Innes, C. S. et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389–393 (2012).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382–2383 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Imakaev, M. et al. Iterative correction of Hi-C data reveals hallmarks of chromosome organization. Nat. Methods 9, 999–1003 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, X., Luan, Y. & Yue, F. EagleC: A deep-learning framework for detecting a full range of structural variations from bulk and single-cell contact maps. Sci. Adv. 8, eabn9215 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Quinlan, A. R. BEDTools: The Swiss-Army Tool for Genome Feature Analysis. Curr. Protoc. Bioinforma. 47, 11 12 1–11 12 34 (2014).ArticleÂ
Google ScholarÂ